Universities Concerned Vaccine Rollout Will Delay Return of International Students

Dr. Joss Reimer, medical lead, Manitoba Vaccine Implementation Task Force draws a dose of the AstraZeneca COVID-19 vaccine at a clinic in Winnipeg, on March 19, 2021. John Woods/The Canadian Press

Australian university sector executives are worried the delayed vaccine rollout will hinder international students’ returning to the country.

“There’s no way the $40 billion-a-year (US$30.5 billion) industry could withstand the loss of a third academic year next year,” Phil Honeywood, CEO of ‎International Education Association of Australia, told The Age.